AzTrials
AzTrials

Zygomatic ImplantROSA-ZYGOMANCT05565157

Flapless Zygomatic Implants Robot-assisted Placement

A study testing Zygomatic implants in people with Zygomatic Implant and Robotic, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Zygomatic implants are indicated for the rehabilitation of the severely atrophic maxilla. Similar to standard implant placement, gaining an optimal position of the zygomatic implants is essential for a predictable prosthetic-driven treatment outcome. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Zygomatic Implant, Robotic
What is being tested?
Zygomatic implants
Type of treatment
Surgery or procedure
How many people
15 participants
Where
1 siteFrance
Study dates
30 Sep 2022to Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients suffering from Maxillary edentulism with severe bone resorption
  • Patients suffering from maxillary edentulism post maxillary defect (carcinologic or traumatic) and free flap reconstruction
  • Patients suffering from post-maxillectomy buccosinusal communication.
  • Age ≥ 18 years old
  • Having signed the informed consent

Who cannot join

  • Patients suffering from chronic sinusitis
  • Patients refusing ROSA robot-guided surgery (unsigned informed consent).
  • Pregnant and nursing women

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • CHU Amiens

    Amiens, 80480

    Sylvie Testellin, Pr, 03 22 08 90 50, testelin.sylvie@chu-amiens.fr

    Jérémie BETTONI, MD

    Recruiting

Other trials in France

About this study

Zygomatic implants are indicated for the rehabilitation of the severely atrophic maxilla. Similar to standard implant placement, gaining an optimal position of the zygomatic implants is essential for a predictable prosthetic-driven treatment outcome.

However, there is no effective mechanism to physically control the drilling trajectory for the zygomatic implants. Therefore, deviation between the actual and planned implant position is inevitable.

Read more

This approach is technically difficult, and is performed by an experienced surgeon.

The development of a surgical technique that is both safer and less invasive is currently possible thanks to robotics. In this project, a robotic assisted new strategy for positioning zygomatic implants will be performed and its efficacy and accuracy will be assess.

Path planning will be carried out on a pre-operative scanner. The ROSA robot (Zimmer®) will guide the several drillings steps. Placement of the zygomatic implant will be performed manually.

Being tested
Zygomatic implants
Keywords
zygomatic implant, robotic, flapless, mini-invasive, ROSA, immediate loading

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Zygomatic implantsProcedure or surgery

    A robotic assisted new strategy for positioning zygomatic implants will be performed and its efficacy and accuracy will be assess

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variation rate between theoretical intraoperative position and post-operative zygomatic implants position

    The accuracy of zygomatic implants positioning will be evaluated by comparing the theoretical intraoperative position and the actual post-operative position by image fusion.

    Measured: one day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Oct 2022
  2. Study start30 Sep 2022
  3. Primary completionSep 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05565157
Sponsor's protocol ID
PI2020_843_0076
Acronym
ROSA-ZYGOMA
Status last verified
Jul 2024
First submitted
30 Sep 2022
Last updated
10 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Zygomatic implants in people with Zygomatic Implant and Robotic, run by Centre Hospitalier Universitaire, Amiens at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sylvie TESTELIN, Pr (03.22.08.90.50, sylvie.testelin@chu-amiens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variation rate between theoretical intraoperative position and post-operative zygomatic implants position (time frame: one day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in